Exam 18: Chronic Myeloproliferative Disorders Ii: Polycythemia Vera, Essential Thrombocythemia, and Idiopathic Myelofibrosis
Exam 1: Morphology of Human Blood and Marrow Cells: Hematopoiesis28 Questions
Exam 2: Bone Marrow29 Questions
Exam 3: The Red Blood Cell: Structure and Function64 Questions
Exam 4: Anemia: Diagnosis and Clinical Considerations33 Questions
Exam 5: Evaluation of Red Blood Cell Morphology and Introduction to Platelet and White Blood Cell Morphology29 Questions
Exam 6: Iron Metabolism and Hypochromic Anemias31 Questions
Exam 7: Megaloblastic Anemias29 Questions
Exam 8: Aplastic Anemia Including Pure Red Cell Aplasia and Congenital Dyserythropoietic Anemia and Paroxysmal Nocturnal Hemoglobinuria48 Questions
Exam 9: Introduction to Hemolytic Anemias: Intracorpuscular Defects: I Hereditary Defects of the Red Cell Membrane36 Questions
Exam 10: Hemolytic Anemias: Intracorpuscular Defects: II Hereditary Enzyme Deficiencies20 Questions
Exam 11: Hemolytic Anemias: Intracorpuscular Defects: III the Hemoglobinopathies75 Questions
Exam 12: Hemolytic Anemias: Intracorpuscular Defects: Iv Thalassemia30 Questions
Exam 13: Hemolytic Anemias: Extracorpuscular Defects51 Questions
Exam 14: Hypoproliferative Anemia: Anemia Associated With Systemic Diseases32 Questions
Exam 15: Cell Biology, Disorders of Neutrophils, Infectious Mononucleosis, and Reactive Lymphocytosis44 Questions
Exam 16: Introduction to Leukemia and the Acute Leukemias74 Questions
Exam 17: Chronic Myeloproliferative Disorders I: Chronic Myelogenous Leukemia24 Questions
Exam 18: Chronic Myeloproliferative Disorders Ii: Polycythemia Vera, Essential Thrombocythemia, and Idiopathic Myelofibrosis56 Questions
Exam 19: Myelodysplastic Syndromes28 Questions
Exam 20: Chronic Lymphocytic Leukemia and Related Lymphoproliferative Disorders29 Questions
Exam 21: The Lymphomas41 Questions
Exam 22: Multiple Myeloma and Related Plasma Cell Disorders45 Questions
Exam 23: Lipid Lysosomal Storage Diseases and Histiocytosis37 Questions
Exam 24: Introduction to Hemostasis113 Questions
Exam 25: Disorders of Primary Hemostasis: Quantitative and Qualitative Platelet Disorders and Vascular Disorders62 Questions
Exam 26: Disorders of Plasma Clotting Factors48 Questions
Exam 27: Interaction of the Fibrinolytic, Coagulation, and Kinin Systems; Disseminated Intravascular Coagulation; and Related Pathology44 Questions
Exam 28: Introduction to Thrombosis and Anticoagulant Therapy66 Questions
Exam 29: Quality Control in the Hematology Laboratory22 Questions
Exam 30: Body Fluid Examination: the Qualitative, Quantitative, and Morphologic Analysis of Serous, Cerebrospinal, and Synovial Fluids36 Questions
Exam 31: Hematology Methods114 Questions
Exam 32: Principles of Automated Differential Analysis25 Questions
Exam 33: Coagulation Procedures61 Questions
Exam 34: Applications of Flow Cytometry to Hematology and Hemostasis20 Questions
Exam 35: Molecular Diagnostic Techniques in Hematopathology34 Questions
Exam 36: Special Stainscytochemistry38 Questions
Select questions type
Almost all patients with this CMPD are positive for the JAK2(V617F) mutation:
(Multiple Choice)
4.7/5
(72)
The myeloproliferative disorder typically associated with the highest platelet count [>1 million/L (1000 109/L)] is:
(Multiple Choice)
5.0/5
(73)
In the hypercellular (prefibrotic) phase of chronic idiopathic myelofibrosis (CIMF), the bone marrow displays panhyperplasia with a predominance of __________.
(Multiple Choice)
4.9/5
(74)
A patient diagnosed with myelofibrosis secondary to gastrointestinal disease may develop a __________ anemia due to excessive blood loss.
(Multiple Choice)
4.9/5
(77)
How is essential thrombocythemia differentiated from chronic myelocytic leukemia?
(Multiple Choice)
4.8/5
(73)
Which clinical manifestations in polycythemia vera are consistent with those of other myeloproliferative syndromes?
(Multiple Choice)
4.8/5
(74)
Metabolic consequences of myelofibrosis include all of the following except:
(Multiple Choice)
4.9/5
(79)
When essential thrombocythemia leads to iron deficiency anemia from associated bleeding, a __________ anemia will result.
(Multiple Choice)
4.9/5
(85)
In polycythemia vera, therapeutic phlebotomies reduce the total red cell mass by removing 350-500 mL over 2-3 days until the hematocrit is maintained at __________ percent.
(Multiple Choice)
4.9/5
(85)
A __________ anemia is found in most myelofibrosis patients at presentation:
(Multiple Choice)
4.7/5
(71)
Which is the expected platelet count in essential thrombocythemia?
(Multiple Choice)
4.9/5
(70)
Hemorrhage and thrombosis are physiologic complications of __________ due to excessive proliferation of the megakaryocyte lineage.
(Multiple Choice)
4.8/5
(79)
Tissue hypoxia and increased erythropoietic activity is an example of ___________ erythrocytosis.
(Multiple Choice)
4.9/5
(84)
What is the usefulness of myelosuppression as a treatment in polycythemia vera?
(Multiple Choice)
4.8/5
(81)
Which of the following are causes of reactive thrombocytosis?
(Multiple Choice)
4.8/5
(91)
In the absolute erythrocytosis, the red cell mass is __________.
(Multiple Choice)
4.9/5
(89)
In secondary erythrocytosis, the underlying mechanism is release of __________ as part of a compensatory effect to minimize impending tissue hypoxia.
(Multiple Choice)
4.7/5
(97)
In both absolute erythrocytosis and relative erythrocytosis the hematocrit is __________.
(Multiple Choice)
4.8/5
(92)
The presence of what gene mutation is one of the major citeria for diagnosis of PV?
(Multiple Choice)
4.9/5
(63)
Showing 21 - 40 of 56
Filters
- Essay(0)
- Multiple Choice(0)
- Short Answer(0)
- True False(0)
- Matching(0)